90206-22-7 Usage
Uses
Used in Pharmaceutical Industry:
1-Piperazineacetonitrile,4-ethyl-(7CI) is used as a chemical intermediate for the synthesis of various pharmaceuticals. Its unique structure allows for the creation of diverse products with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 1-Piperazineacetonitrile,4-ethyl-(7CI) serves as an intermediate in the production of agrochemicals, contributing to the development of effective solutions for agricultural needs.
Used in Drug Development:
1-Piperazineacetonitrile,4-ethyl-(7CI) is utilized as a building block in the research and development of new drugs. Its distinctive chemical properties make it a valuable component in the design of innovative pharmaceutical compounds.
Used in Bioactive Compounds Synthesis:
1-Piperazineacetonitrile,4-ethyl-(7CI) is also used in the synthesis of bioactive compounds, where its unique structure can contribute to the development of substances with potential biological activity.
It is important to handle 1-Piperazineacetonitrile,4-ethyl-(7CI) with care due to its potential hazards and toxicity, ensuring safety in its application across various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 90206-22-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,0,2,0 and 6 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 90206-22:
(7*9)+(6*0)+(5*2)+(4*0)+(3*6)+(2*2)+(1*2)=97
97 % 10 = 7
So 90206-22-7 is a valid CAS Registry Number.
InChI:InChI=1/C8H15N3/c1-2-10-5-7-11(4-3-9)8-6-10/h2,4-8H2,1H3
90206-22-7Relevant academic research and scientific papers
3-IMIDAZOLYL-INDOLES FOR THE TREATMENT OF PROLIFERATIVE DISEASES
-
Page/Page column 138, (2008/12/04)
The invention relates to 3-heterocyclyl indolyl compounds capable of inhibiting the interaction between p53, or variants thereof, and MDM2 and/or MDM4, or variants thereof, respectively, said compounds having the formula (I) wherein R1, R2, R3, R4, RA, Y and Y are as defined in the specification. Due to their activity, the compounds are useful in the treatment of various disorders and diseases mediated by the activity of MDM2 and/or MDM4, or variants thereof, such as inflammatory or proliferative diseases or in the protection of cells.
